The aim of this fundraising is for CALIXAR to become a leader in the early discovery segment of drug development based on complex therapeutic targets (membrane proteins), a market predicted to be worth €70bn by 2025.
About the Digital RESI Europe Experience 2020 :
The Redefining Early Stage Investments (RESI) conference series was created by Life Science Nation (LSN) to bring together startups with early-stage investors and strategic channel partners. The goal was to maximize the capability of these companies, from seed to series B, to find partners who are a fit for their technology and stage of development.
For more information about this event : Digital RESI Europe – 2020
![](https://cdn.prod.website-files.com/63f5f88e1fae3d7b941d87bd/6464ac64f4191cab11d218f9_Capture-d%E2%80%99e%CC%81cran-2020-06-01-a%CC%80-14.02.00-768x294.jpg)